Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim–sulfamethoxazole: lessons from an observational cohort study

BACKGROUND: The recommended treatment of Pneumocystis jirovecii pneumonia (PCP) is high-dose trimethoprim–sulfamethoxazole (TMP–SMX) in an equivalent of TMP 15–20 mg/kg/day and SMX 75–100 mg/kg/day for 2 or 3 weeks. High rates of adverse events are reported with this dose, which raises the question...

Descripción completa

Detalles Bibliográficos
Autores principales: Creemers-Schild, Dina, Kroon, Frank P., Kuijper, Ed. J., de Boer, Mark G. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889633/
https://www.ncbi.nlm.nih.gov/pubmed/26471512
http://dx.doi.org/10.1007/s15010-015-0851-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889633/
https://www.ncbi.nlm.nih.gov/pubmed/26471512
http://dx.doi.org/10.1007/s15010-015-0851-1

Ejemplares similares